Pit additive

R1 RCM to Restate Certain Previously Issued Financial Statements Due to Errors in Accounting for Expenses Associated with Historical Acquisitions

Retrieved on: 
Monday, November 13, 2023
EBITDA, Pit additive, Ernst & Young, Audit committee, Bank statement, Reliability-centered maintenance, GAAP, RCM, Adjustment, Business operations, Impact investing

MURRAY, Utah, Nov. 13, 2023 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM) (“R1”), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced its decision to restate its previously issued financial statements for the years ended December 31, 2022 and 2021 and interim periods, as well as for the first two quarters of 2023.

Key Points: 
  • Immediately prior to the scheduled filing of its Form 10-Q for the third quarter 2023, R1 identified errors related to the accounting for certain acquiree compensation costs (e.g., transaction bonuses and accelerated equity award vesting) incurred as a result of historical acquisitions.
  • These expenses should have been recorded as “Other expenses” within the consolidated statements of operations and comprehensive income and instead were included in the purchase price allocations and ultimately recorded as goodwill in the consolidated balance sheets.
  • R1 has determined that the drivers of the corrections are acquiree compensation expenses equal to approximately $7.8 million for 2022 and $8.4 million for 2021.
  • Based on information currently available, R1 does not expect a material impact to 2022 and 2021 revenue or Adjusted EBITDA.

Hinge Health Continues to Advance Women’s Pelvic Care with Breathing Guidance and Smart Trainer Device

Retrieved on: 
Tuesday, September 26, 2023
Consumer Electronics, Technology, Health, Women, Wearables, Mobile Technology, Health Technology, Medical Devices, Apps, Applications, Software, Consumer, Telemedicine, Virtual Medicine, Exercise, DSM-IV codes, Pelvic pain, Pregnancy, Pit additive, Life, Anxiety, Therapy, Incontinence, Woman, Pelvic floor, Abdomen, Weightlifting, Swelling, Menopause, Happiness, Meditation, Research, Mental health, Urinary incontinence, Birth control

Hinge Health’s Pelvic Health Program has seen tremendous adoption and effectiveness with over 15,000 participants enrolling since the program was introduced in May 2023.

Key Points: 
  • Hinge Health’s Pelvic Health Program has seen tremendous adoption and effectiveness with over 15,000 participants enrolling since the program was introduced in May 2023.
  • “For too long, women have been suffering in silence with pelvic conditions, without access to high-quality care,” said Inessa Lurye, Head of Women’s Health at Hinge Health.
  • Breathing Guidance: A new breathing and meditation experience helps members reduce stress and anxiety as well as decrease muscle tension, which can help women address their pelvic health symptoms.
  • Care is personalized around one of four pelvic floor needs: pregnancy and postpartum, bladder control, pelvic pain, and pelvic strength.

Neurocrine Biosciences Presents New INGREZZA® (valbenazine) Capsules Data Demonstrating Early and Sustained Improvements in Chorea Associated With Huntington's Disease

Retrieved on: 
Monday, August 28, 2023
Huntington's disease, Pit additive, KINECT, Lancet Neurology, Week, Disease, McGovern Medical School, Neurocrine Biosciences, Clinical Global Impression, Movement disorder, The Lancet, MDS, Capsule, Movement, TMC, SAN, Chorea, Parkinson's disease, FANA, Neurology, Poster, FAAN, FDA, Safety, Pharmaceutical industry, HD

SAN DIEGO, Aug. 28, 2023 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data on now FDA-approved INGREZZA® (valbenazine) capsules for the treatment of adults with chorea associated with Huntington's disease (HD), including exploratory results from the Phase 3 KINECT®-HD study, which showed consistently greater improvements in HD chorea with INGREZZA versus placebo from Week 2 to Week 12. These data will be presented at the MDS International Congress of Parkinson's Disease and Movement Disorders®August 27-31 in Copenhagen, Denmark.

Key Points: 
  • These data will be presented at the MDS International Congress of Parkinson's Disease and Movement Disorders®August 27-31 in Copenhagen, Denmark.
  • "The exploratory analysis from our KINECT-HD study further exemplifies the value of INGREZZA as a now approved medication for HD chorea with improvements seen with treatment as early as two weeks," said Eiry W. Roberts, M.D., Chief Medical Officer at Neurocrine Biosciences.
  • "This exploratory analysis has increased our insight regarding the early and sustained improvements in chorea severity."
  • Additional HD chorea presentations at the MDS International Congress of Parkinson's Disease and Movement Disorders include:

ISSRDC Session to Focus on Advancing Cardiovascular Research in Low Earth Orbit

Retrieved on: 
Wednesday, July 5, 2023
ISS National Lab, Heart, Pit additive, Stanford University, AAS, Cardiovascular disease, Hyatt Regency Seattle, International Space Station, Research, Regenerative medicine, American Astronautical Society, HIV disease progression rates, NASA, Patient, LEO, CASIS, Growth, Government, Cedars-Sinai Medical Center, Scientific research on the International Space Station, Stem Cell Reports, Environment, Conference, Hyatt, International Space Development Conference, ISS, Pharmaceutical industry, Science

SEATTLE, July 5, 2023 /PRNewswire/ -- A fireside chat with space station researcher Arun Sharma at the 12th annual International Space Station Research and Development Conference (ISSRDC) will highlight cardiovascular research in low Earth orbit (LEO).

Key Points: 
  • SEATTLE, July 5, 2023 /PRNewswire/ -- A fireside chat with space station researcher Arun Sharma at the 12th annual International Space Station Research and Development Conference (ISSRDC) will highlight cardiovascular research in low Earth orbit (LEO).
  • The LEO environment is beneficial for this area of research because microgravity causes changes in heart function similar to those seen in patients with cardiovascular disease on Earth, but at a quicker rate.
  • ISSRDC brings together leaders from the commercial sector, U.S. government agencies, and academic communities to foster innovation and discovery onboard the International Space Station.
  • To learn more about ISSRDC, including how to register, exhibit, or become a conference sponsor, please visit the conference homepage .

LithiumBank Files Preliminary Economic Assessment Technical Report for the Boardwalk Lithium Brine Project, West-Central Alberta

Retrieved on: 
Wednesday, June 21, 2023
Lithium, Technical report, Techno-economic assessment, DLE, Pit additive, Electrical conductor, Hydrogen, Carbon footprint, Magnesium, LHM, HCL, Economics, Carbon, USD, Government, Public expenditure, Next, Qualified personal residence trust, PEA, Fresh water, Engineering, Local government in Canada, OPEX, ITC, Hatch Ltd, Park Place, Boardwalk, GLJ, CO2, IRR, Speciality chemicals, Oil, Transport, Western Canada

CALGARY, Alberta, June 21, 2023 (GLOBE NEWSWIRE) -- LithiumBank Resources Corp. (TSX-V: LBNK) (OTCQX: LBNKF) (“LithiumBank” or the “Company”) is pleased to announce the filing of the Boardwalk Lithium Brine Project Preliminary Economic Assessment (“PEA”) Technical report entitled “Preliminary Economic Assessment (PEA) for LithiumBank Resources Boardwalk Lithium-Brine Project in West- Central Alberta, Canada” effectively dated June 16, 2023, originally announced May 25th, 2023 .

Key Points: 
  • CALGARY, Alberta, June 21, 2023 (GLOBE NEWSWIRE) -- LithiumBank Resources Corp. (TSX-V: LBNK) (OTCQX: LBNKF) (“LithiumBank” or the “Company”) is pleased to announce the filing of the Boardwalk Lithium Brine Project Preliminary Economic Assessment (“PEA”) Technical report entitled “Preliminary Economic Assessment (PEA) for LithiumBank Resources Boardwalk Lithium-Brine Project in West- Central Alberta, Canada” effectively dated June 16, 2023, originally announced May 25th, 2023 .
  • In addition to the Boardwalk project, LithiumBank also holds two other development ready, district scale assets in Western Canada, Park Place (AB) & Saskatchewan.
  • “The Boardwalk PEA sets the stage for our team to pursue advanced lithium resource development in Western Canada” commented Rob Shewchuk CEO & Director of LithiumBank.
  • The PEA Technical Report was prepared by the following Qualified Persons; Roy Eccles, P. Geol.

Gold Resource Corporation Reports Strong First Quarter Gold Production and a Strengthened Management Team at the Mine

Retrieved on: 
Tuesday, April 25, 2023
Mining, Minerals, Natural Resources, Shareholder, Pit additive, Zinc, Metallurgy, Silver, Lead, Back Forty Mine, Don, Organization, Three Sisters, Gold, Mexican, Copper, Health, Mexican Center League, NYSE, Clothing, Management, Sanctuary (1933 film)

Gold Resource Corporation (NYSE American: GORO) (the “Company”) sold a total of 6,508 ounces of gold and 294,815 ounces of silver in the first quarter of 2023 for a total of 10,055 gold equivalent ounces.

Key Points: 
  • Gold Resource Corporation (NYSE American: GORO) (the “Company”) sold a total of 6,508 ounces of gold and 294,815 ounces of silver in the first quarter of 2023 for a total of 10,055 gold equivalent ounces.
  • Additionally, during the quarter, the Company sold 3,060 tonnes of zinc, 332 tonnes of copper, and 1,417 tonnes of lead.
  • A total of $5 million was invested in the Don David Gold Mine and Back Forty Project.
  • “Our 2023 annual production at the Don David Gold Mine is off to a good start.

Jacobs to Manage Infrastructure Program for Fulton County Schools

Retrieved on: 
Wednesday, March 15, 2023
Annual report, Ventilation, City, Heat, Learning, FCS, Financial condition report, Analysis, NYSE, Result, Conversation, School, Management, Partnership, Teaching, Infrastructure Investment and Jobs Act, Fulton County School System, Capital, Government, HVAC, Pit additive, COVID-19, Risk, Student, Environment, Engineering, Security (finance), Safety, Private sector, Air conditioning, Nursing, Tutoring

DALLAS, March 15, 2023 /PRNewswire/ -- Jacobs (NYSE:J) was selected by Fulton County Schools (FCS) in Atlanta, Georgia to manage the Education Special Purpose Local Option Sales Tax (ESPLOST) Capital Improvement Program. The current program will implement FCS' Capital Plan 2027, which includes $648 million in capital improvements for FCS facilities, safety and technology systems.

Key Points: 
  • DALLAS, March 15, 2023 /PRNewswire/ -- Jacobs (NYSE:J) was selected by Fulton County Schools (FCS) in Atlanta, Georgia to manage the Education Special Purpose Local Option Sales Tax (ESPLOST) Capital Improvement Program.
  • Under the new 66-month contract, Jacobs will manage infrastructure modernization projects, including the new construction of five schools, and major renovations of 18 other schools and two non-instructional facilities within the school district.
  • "Fulton County Schools is pleased to continue its relationship with Jacobs.
  • Engineering News-Record has ranked Jacobs as the Number 1 Program Management Firm for the third consecutive year.

ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep

Retrieved on: 
Monday, March 13, 2023
Woman, Diabetes, Self-assessment, Sleep disorder, Pit additive, United Kingdom, Gen, NYSE, Somnolence, ASX, Spotify, Apple, National Sleep Foundation, Risk, Obesity, Mixed anxiety–depressive disorder, Health, RMD, Xerostomia, Silent Generation, Generation Z, Depression, Generator, Patient, Irritability, Sleep, Mental health, Sleep apnea, Consumer Technology Association, SAN, ResMed, Generation X, Sore throat, Pharmaceutical industry, Nursing, Tobacco, Millennials, Baby boomers

8 in 10 respondents reported one or more symptoms of sleep disruption related to sleep quality; Mexico (87%), France (87%), and South Korea (85%) had the highest rates of reported symptoms, while Japan (60%) had the lowest.

Key Points: 
  • 8 in 10 respondents reported one or more symptoms of sleep disruption related to sleep quality; Mexico (87%), France (87%), and South Korea (85%) had the highest rates of reported symptoms, while Japan (60%) had the lowest.
  • 60% of women report being satisfied with their quantity of sleep (the least of any gender), compared to 68% of men and 65% of nonbinary respondents.
  • Additionally, 49% of respondents said their doctor has never asked them proactively about their sleep quality.
  • To learn more about ResMed’s 2023 Global Sleep Survey or to take a quick self-assessment for your risk of sleep apnea, visit SleepForBetterTomorrow.com .

Sofwave Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights

Retrieved on: 
Wednesday, March 8, 2023
Growth, Eyebrow, Patent, Elastin, Cellulite, FDA, Skin, Sofwave Medical, Pit additive, Collagen, COVID, TASE, IP, Patient, Patient safety, Warburg Pincus, Pharmaceutical industry

- 2022 Recurring Revenue Up 177%, to $7.2M; Representing More Than 20% of Revenue

Key Points: 
  • - 2022 Recurring Revenue Up 177%, to $7.2M; Representing More Than 20% of Revenue
    SAN CLEMENTE, Calif., March 08, 2023 (GLOBE NEWSWIRE) -- Sofwave Medical Ltd (TASE: SOFW), an emerging leader in energy-based non-invasive, aesthetic medical devices for practitioners worldwide, reported fourth quarter and full year 2022 financial results for the period ended December 31, 2022, and recent business highlights.
  • Q4 record Revenues of $13.8M; 55% year-over-year growth
    Full year 2022 Revenue of $35.6M, a year-over-year increase of 63%
    Cash as of December 31, 2022: $32M
    Mr. Louis Scafuri, Sofwave CEO commented, “Our impressive 2022 top-line results were led by strong performances in both North America and Asia.
  • Additionally, our digital marketing consumer awareness efforts have helped to drive the demand for Sofwave treatments as evidenced by our significant pulse sales growth in 2022.
  • As global market conditions continue to be favorable, we see demand for our Sofwave treatments increase and are well-positioned for meaningful further growth.

Global CIO Report Reveals Growing Urgency for Observability and Security to Converge

Retrieved on: 
Tuesday, January 24, 2023
Security, Data Management, Technology, Artificial Intelligence, Software, Cloud, Pit additive, Organization, Automation, NYSE, DT, Research, Risk, Artificial Intelligence for IT Operations, AI, Medical device, Risk management, DevOps, Dynatrace

CIOs and senior DevOps managers are looking to DevSecOps processes, the convergence of observability and security, and the increased use of AI and automation to balance accelerated innovation with reliability and security.

Key Points: 
  • CIOs and senior DevOps managers are looking to DevSecOps processes, the convergence of observability and security, and the increased use of AI and automation to balance accelerated innovation with reliability and security.
  • The complimentary 2023 Global CIO Report , “Observability and Security Convergence: Enabling Faster, More Secure Innovation in the Cloud,” is available here .
  • The research reveals the following:
    90% of organizations say digital transformation has accelerated in the past 12 months.
  • To accomplish this, organizations require a unified platform that can converge observability and security data to eliminate the silos between teams.